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Abstract
Artemisia annua belongs to the asteraceae family, indigenous to the mild climate of Asia. The aim of this study
was to overview its anti-malarial properties, immunosuppressive properties, anti-inflammatory properties and
anti-cancer properties. This systematic review was carried out by searching studies in PubMed, Medline, Web of
Science, and IranMedex databases. The initial search strategy identified approximately ninety eight references. In
this study, forty six studies were accepted for further screening and met all of our inclusion. The search terms
were “Artemisia annua”, “therapeutic properties”, “and pharmacological effects”. Artemisia annua is commonly
used for its anti-malarial, immunosuppressive anti-inflammatory properties. Artemisia annua contributes to the
treatment of various diseases such as diabetes, heart diseases, arthritis and eczema and possesses various effects
such as antibacterial, antioxidant, anticoccidial, and antiviral effects. Furthermore, it was said to be good for
cancer treatment. In this study, anti-malarial, immunosuppressive, anti-inflammatory properties of this plant are
presented using published articles in scientific sites.
Keywords: Artemisia annua, Phytochemicals, Therapeutic effects, Pharmacognosy, Alternative and
complementary medicine
1. Introduction
1.1. Background
Herbal medicine has been used from ancient times to the present day, and has lots of progress for healing purposes
(1-10). Artemisia annua is a member of Asteraceae family, a very economically important crop in China, indigenous
to the mild climate of Asia, but localized in many countries, including scattered areas of North America (11, 12). It
is an annual plant, and its stem is upright and violet brown. The plant itself is glabrous, and can have a natural
growth of up to one meter (13-15). Based on Chinese medicine, treating diseases with Artemisia annua has a long-
established tradition: diseases including fever, acanthamoebiasis, cancer, schistosomiasis, HIV, hepatitis-B and
Leishmaniasis have been known to be treated with Artemisia annua (16, 17). Recent research illustrated that this
plant possesses a very high level of oxygen radical absorbance capacity (ORAC). Furthermore, it contains high
phenolic compounds (18-20), resulting in possessing high antioxidant activity. Chemical analysis of this plant shows
five major groups containing coumarin, flavones, flavonols and phenolic acids. (21). Flavonoids are known for their
redox properties associated with oxidizing chain reactions. It has been stated that a negative correlation has been
found between the presence of the mentioned composition and incidence of systemic diseases (22-24). Since few
researches have been carried out regarding the interactive effect of artemisinin and flavonoids and their relationship
with malaria and cancer, the aim of this study was to overview the anti-malarial properties, immunosuppressive
properties, anti-inflammatory properties, and anti-cancer properties of this plant.
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1.2. Statement of problem
It is a fact that herbal medicines possessing natural essential chemical compounds in their profile could fulfill the
primary needs and be a prerequisite for human beings to cure their diseases. Derivatives of natural products make up
to half of all drugs in clinical use. The diversity of natural compounds in herbs, and their different functions in
preventing and treating various diseases, together with their natural properties and compatibility, with the body
having no adverse effects (providing their proper usage), causes people to incline more to their consumption, and
researchers are highly inclined to carry out studies on these herbs and diagnose their therapeutic properties.
However, there is still a lot of confusion regarding their applicability, perniciousness, assortment, and arrangement.
To try to overcome these problems, numerous studies have been carried out, concentrating on identification of
medicinal herbs, triggering economically remarkable opportunities for farmers, and also relating cultivation,
harvesting and agronomic conditions, to the ability of herbs in order to generate a favorable chemical and
pharmacological profile.
1.3. Objective of research
This systematic review is aimed to overview chemical compounds and traditional usages of Artemisia annua as well
as its anti-cancer and anti-malarial properties, immunosuppressive properties and anti-inflammatory properties in
detail.
2. Material and Methods
2.1. Research design and selection criteria
This systematic review was carried out by searching studies in PubMed, Medline, Web of Science, and IranMedex
databases. The initial search strategy identified around 128 references. In this study, 46 studies were accepted for
further screening and met all of our inclusion criteria (article in English, have full text, related to therapeutic effects
of Artemisia annua L, and dated mainly from the year 2009 to 2016). The search terms were “Artemisia annua”,
“anti-cancer”, “anti-malarial properties”, “pharmacological effects”. Inclusion criteria were the following keywords
used, to search for the relevant articles published from March 1990 to March 2016, their full text should be
available, in English. Articles included, consisted of clinical trials, in vitro, in vivo, review, or meta-analysis studies.
2.2. Quality assessment
Different parts of each article consisting of the title, abstract, introduction, methods, results, discussion, and
conclusion were assessed. The inclusion and exclusion criteria, sampling method, existence of valid instruments
were also checked. Based on the search results, fifty six studies were identified; however, nine articles were
excluded from the review and forty seven articles were left for more analysis.
3. Results
3.1. Anti-Malarial properties
Mechanism of action of flavonoids in Artemisia annua was investigated in a study. The results showed that AaF3H
is combined in the cultivation variety whenever there is a higher level of flavonoids, compared with whenever there
is a lower level of flavonoids, meaning that AaF3H is potentially suitable for regulation of flavonoids biosynthesis
in Artemisia annua through metabolic engineering (20). Experimental conditions were carefully studied and the
premium conditions were selected. The separations were achieved on pre-coated silica gel plates, G 60F254. The
analysis of statistical data suggested that in biological samples, this method can contribute to the simultaneous
counting of AN and AA (25).  Three new monoterpene synthases of Artemisia annua were investigated. Camphene
and 1, 8-cineole were the major products, and also β-myrcene. Despite  the fact that both Mg(2+) and Mn(2+) were
able to support their catalytic activities, only Mn(2+) can be applicable for both  AaTPS2 and AaTPS5 (13).
Artemisinin, transformed form of Artemisia, is of high importance regarding its different therapeutic and anti-
malarial activity, the ABC genes available in this plant contribute to an increase in yield of this transformed product
(26). In a study, transgenic plants containing AaWRKY1 were analyzed. The results showed that AaWRKY1
increased the artemisinin content through ADS and CYP regulation (27). As far as AN molecule in Artemisia is in
low concentration, it is quite expensive, and different genetic manipulation approaches are difficult to do; thus,
regulation of AN genetic pathway and other biological processes is costly (28). Artemisinin and total flavonoids
levels were higher in samples obtained from high land areas (western and south western region) compared to those
obtained from lowland regions. Findings show that the active components in Artemisia annua cultivated and used in
Uganda, vary with geographical regions and this calls for standardization by source (29). In a clinical trial study, it
showed that compared to pure artemisinin, its dried leaves give 40-fold less artemisinin required (30). In an animal
study, the anti- malarial efficacy of the whole plant was investigated and results showed that it is more effective than
http://www.ephysician.ir
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a comparable dose of pure artemisinin. It shows that WP overcomes existing resistance to pure artemisinin. In an in
vitro study, resilience of whole plant (WP) against drug resistance was examined compared to pure artemisinin
(AN). Anti-malarial efficacy of WP treatment confirmed and gave more hints to further research in this area (31).
3.2. Immunosuppressive properties
In an animal study, immunosuppressive activity of ethanol extract of Artemisia annua was evaluated for splenocyte
proliferation, and the result was shown that the Artemisia annua is used for treatment of some autoimmune diseases
and it can be considered as an immunosuppressant for future research (32). The extracted parts of the plant were
purified and evaluated.  Inhibitory effects of extract on the calmodulin activity was observed through increase in the
fluorescence emission of calmodulin (33).
3.3. Anti-inflammatory properties
The safety and efficacy of a dietary supplement derived from Artemisia annua was investigated in osteoarthritis
(OA) of the hip or knee. This plant was shown to have potential as an anti-inflammatory/analgesic in OA. Decrease
in pain over 12 weeks with ART 150 mg is clinically confirmed (34).
3.4. Anti-cancer properties
Anticancer effect of artemisinin and anti-metastatic effects of pKAL were investigated on advanced metastatic
breast cancer cells. The results suggest that pKAL can act as a therapeutic agent against cancer metastasis at least
via inhibiting the adhesion of cancer cell to ECs (35). Long-term treatment with Artemisia annua combined with
bicalitumide resulted in remarkable improvement of advanced metastasized prostate carcinoma. Human studies are
required to evaluate the clinical benefit of Artemisia annua in prostate cancer (36). Extract of Artemisia annua was
fractionated and evaluated on three human cancer cell lines. Results indicated that F7 is able to in SKNMC cells.
Furthermore, these results indicated that F7 enhances the antitumor activity of DOX as well as increases in the
cytotoxicity of DOX through modulating the activity of multidrug resistant cancer cells and inducing apoptosis (37).
Antiproliferative effects of different parts of Artemisia were investigated. Results demonstrated that the difference
between cytotoxic effect of this plant rely not only on the concentration of its essential oils, but on the target cells
and the botanical parts of essential oils as well (38). The effect of arsantin on cellular difference in the human
promyelocytic leukemia cell was investigated. Arsantin interactively increased difference between HL-60 cells in a
dose-dependent manner. The ability of arsantin in increasing the difference between leukemia cells is likely to
improve results in the therapy of acute promyelocytic leukemia (39). Anticancer effects of artemisia including the
proliferation, apoptosis and metastasis effect of human osteosarcoma cells were investigated. The influence of this
plant to human osteosarcoma cells was observed. Results suggest that the extract of Artemisia annua restrains the
proliferation and metastasis of human osteosarcoma cells and promotes the tumour cell apoptosis (40). In an in vitro
study, anti-cancer properties of Artemisia annua were investigated. The results showed that fraction of artemisia
caused to inhibit proliferation of melanoma cells in a concentration-related manner and increase over-expression of
both Bax and cytochrome c. thus, it was shown that its ingredients may be potential as therapeutic candidates for
melanoma (41). Transgenic plants were analyzed to consider their taxadiene production. Results demonstrate the
possibility of genetic engineering of the taxane biosynthetic pathway in Artemisia annua L. for the production of
taxadiene (42, 43).
4. Discussion
Artemisinin derived from the medicinal plant Artemisia spp. It is an effectual anti-malarial agent. Terpenes (mainly
mono and sesqui), flavonoids, and polyphenolic acids are main chemical constituents of this herb. While the
majority of herbs should be heated severely (44), this plant should be drenched; several factors are involved in
antimalarial effects of this plant including the presence of flavonoids in collaboration to artemisinin and the
existence of aromatic oils of the plant (45). It is stated that Artemisinin-based remedies are of the most helpful
therapies with anti-malarial properties (46). The emergence of artemisinin resistance is mainly due to the application
of artemisinin-based therapies (47). Flavonoids were found to incorporate anti-malaria and anti-cancer compounds
(48) in Artemisia annua. In anti-cancer activity of this plant, several factors are involved: 1) presence of
endoperoxide group. 2) Interaction with iron complexes in the blood; 3) influence of flavonoids as flavones and
flavonols. Specifically, flavonoid were shown to prohibit cancer cell growth as well as cell proliferation and cell
Apoptosis
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5. Conclusions
In this study, Anti-Malarial properties, immunosuppressive properties, anti-inflammatory properties and anti-cancer
properties of this valuable plant were overviewed. Artemisia annua has been widely used to treat autoimmune
diseases such as systemic lupus erythematosus and rheumatoid arthritis in traditional Chinese medicine. Findings of
this study showed that synergistic effects of artemisinin and its flavonoids compounds and their biological
interaction between malaria and cancer can be a rich source to anti-malarial, immunosuppressive, anti-inflammatory,
and anti-cancer properties of this plant. However, more in vivo studies are required to find new compounds
involving the afore-mentioned properties.
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